bcode, So, when you say, Joe R's statement a
Post# of 30028
Posted On: 09/24/2014 12:00:22 PM
bcode,
So, when you say,
this is the same Joe R below...
Dr. Joseph Rubinfeld
In addition to his efforts in founding Amgen, Dr. Rubinfeld has a fifty year history in pharmaceutical and consumer product development.
His accomplishments include the development of the multi-billion dollar antibiotic Amoxicillin as well as the invention and development of the first synthetic biodegradable detergent.
In 1984 Dr. Rubinfeld won the prestigious Common Wealth Award for Science and Invention . This award was a testament to his proclivity for achieving major inventions, represented by the numerous patents obtained during his distinguished career.
Dr. Rubinfeld began his career as a research scientist with several pharmaceutical and consumer product companies including Schering Plough, Colgate Palmolive and Upjohn. He served for twelve years at Bristol Myers, where in addition to developing Amoxicillin and Cefadroxil, he was instrumental in licensing their original anti-cancer line of products, including Mitomycin, Etoposide, and Bleomycin...
http://www.generex.com/index.php/id/294
During that time he oversaw the company's initial public offering and its rise to a multi-billion dollar market capitalization, fueled by the commercialization of four anti-cancer drugs, including Pentostatin and Decitabine, and the issuance of over 20 drug patents in his name.
http://investor.generex.com/releasedetail.cfm...eID=400980
He has obtained over 100 patents during his distinguished career.
http://www.regenicin.com/Investor-Relations/N...00824.html
FDA Issues Orphan Status Approval for PermaDerm®June 12, 2012
http://www.regenicin.com/Investor-Relations/N...20612.html
So, when you say,
Quote:
Joe R's statement at the meeting was "we're ready to launch a diagnostic in four months... we're there!"
this is the same Joe R below...
Dr. Joseph Rubinfeld
In addition to his efforts in founding Amgen, Dr. Rubinfeld has a fifty year history in pharmaceutical and consumer product development.
His accomplishments include the development of the multi-billion dollar antibiotic Amoxicillin as well as the invention and development of the first synthetic biodegradable detergent.
In 1984 Dr. Rubinfeld won the prestigious Common Wealth Award for Science and Invention . This award was a testament to his proclivity for achieving major inventions, represented by the numerous patents obtained during his distinguished career.
Dr. Rubinfeld began his career as a research scientist with several pharmaceutical and consumer product companies including Schering Plough, Colgate Palmolive and Upjohn. He served for twelve years at Bristol Myers, where in addition to developing Amoxicillin and Cefadroxil, he was instrumental in licensing their original anti-cancer line of products, including Mitomycin, Etoposide, and Bleomycin...
http://www.generex.com/index.php/id/294
During that time he oversaw the company's initial public offering and its rise to a multi-billion dollar market capitalization, fueled by the commercialization of four anti-cancer drugs, including Pentostatin and Decitabine, and the issuance of over 20 drug patents in his name.
http://investor.generex.com/releasedetail.cfm...eID=400980
He has obtained over 100 patents during his distinguished career.
http://www.regenicin.com/Investor-Relations/N...00824.html
FDA Issues Orphan Status Approval for PermaDerm®June 12, 2012
http://www.regenicin.com/Investor-Relations/N...20612.html
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼